FDA Advisers Back COVID-19 Vaccine Pivot in Move Toward Annual Shot

A view of the Food and Drug Administration's White Oak campus in Silver Spring, Md., on Dec. 17, 2020. Brendan Smialowski/AFP via Getty Images

Experts who advise the U.S. Food and Drug Administration (FDA) on immunizations were supportive on Jan. 26 of a planned pivot on COVID-19 vaccines.

Members of the Vaccines and Related Biological Products Advisory Committee voted to recommend the FDA stop using the original vaccines, which only target the obsolete Wuhan strain, in favor of new bivalent shots that are currently only used as boosters.